Last reviewed · How we verify

NCT05297058

Associations of Age Measures With Serum Anti-Müllerian Hormone

Completed Last updated 28 October 2024
What this trial tests

trial in Aging in 50 participants. Completed in 20 March 2024.

Timeline
1 July 2022
Primary endpoint
20 March 2024
20 March 2024

Quick facts

Lead sponsorInsel Gruppe AG, University Hospital Bern
StatusCompleted
Study typeOBSERVATIONAL
Enrollment50
Start date1 July 2022
Primary completion20 March 2024
Estimated completion20 March 2024
Sites1 location across Switzerland

Conditions studied

Sponsor

Insel Gruppe AG, University Hospital Bern

Who can join

Adults 35 to 45, female only, with Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to assess the association between aging and serum anti-müllerian hormone.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Aging

Currently open trials in the same condition.

Other Insel Gruppe AG, University Hospital Bern trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05297058.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing